PHARMACEUTICALS, PHOSPHORUS-CONTAINING 2-ISOXAZOLINES AND ISOXAZOLES CONTAINED THEREIN, AND PROCESSES FOR THE PREPARATION OF THESE HETEROCYCLIC COMPOUNDS

Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds Pharmaceuticals containing or composed of at least one compound of the formula I and/or one of its physiologically tolerated salts where appropria...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GEBERT, ULRICH, BARTLETT, ROBERT R, DICKNEITE, GERHARD, SCHORLEMMER, HANS U, SCHWAB, WILFRIED, SEDLACEK, HANS H
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GEBERT, ULRICH
BARTLETT, ROBERT R
DICKNEITE, GERHARD
SCHORLEMMER, HANS U
SCHWAB, WILFRIED
SEDLACEK, HANS H
description Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds Pharmaceuticals containing or composed of at least one compound of the formula I and/or one of its physiologically tolerated salts where appropriate, where the compounds of the formula I can, where appropriate, be in the form of pure stereoisomers or mixtures thereof; formula I is: (I) in which R1 = organic radical or halogen, A = C,C single or C,C double bond, n = 0, 1 or 2, and X and Y = alkyl radical or = -OR2 or -NR2R3 with R2 and R3 = H or optionally substituted aliphatic radical. The pharmaceuticals are suitable for the prophylaxis and/or treatment of diseases of the immune system, especially of tumors, infections and/or autoimmune diseases of the human or animal body and for use as adjuvants for vaccines. Some of the compounds of the formula I are new; the compounds can be prepared by special processes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA1329604C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA1329604C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA1329604C3</originalsourceid><addsrcrecordid>eNqFjEEKwjAQRbtxIeoZzAEsaCuCy2E6NYGaCZkU1I2IxJWooJfxtqZS1y6Gz3__McPs7TT4LSC1wSA0MlNOs6TzreTINoCxxm5UkRvhHRy4MZZEga3UD6Tai1SpoMmTsbOv4TwjiSShZt9NiZADD8GwVVx3SEhpCpTMPTYG06ut49ZWMs4Gl9P1GSd9jrJpTQF1Hh_3Y3w-Tud4i68jwqIs1qv5Esv_xgcN-ELC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICALS, PHOSPHORUS-CONTAINING 2-ISOXAZOLINES AND ISOXAZOLES CONTAINED THEREIN, AND PROCESSES FOR THE PREPARATION OF THESE HETEROCYCLIC COMPOUNDS</title><source>esp@cenet</source><creator>GEBERT, ULRICH ; BARTLETT, ROBERT R ; DICKNEITE, GERHARD ; SCHORLEMMER, HANS U ; SCHWAB, WILFRIED ; SEDLACEK, HANS H</creator><creatorcontrib>GEBERT, ULRICH ; BARTLETT, ROBERT R ; DICKNEITE, GERHARD ; SCHORLEMMER, HANS U ; SCHWAB, WILFRIED ; SEDLACEK, HANS H</creatorcontrib><description>Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds Pharmaceuticals containing or composed of at least one compound of the formula I and/or one of its physiologically tolerated salts where appropriate, where the compounds of the formula I can, where appropriate, be in the form of pure stereoisomers or mixtures thereof; formula I is: (I) in which R1 = organic radical or halogen, A = C,C single or C,C double bond, n = 0, 1 or 2, and X and Y = alkyl radical or = -OR2 or -NR2R3 with R2 and R3 = H or optionally substituted aliphatic radical. The pharmaceuticals are suitable for the prophylaxis and/or treatment of diseases of the immune system, especially of tumors, infections and/or autoimmune diseases of the human or animal body and for use as adjuvants for vaccines. Some of the compounds of the formula I are new; the compounds can be prepared by special processes.</description><edition>5</edition><language>eng ; fre</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19940517&amp;DB=EPODOC&amp;CC=CA&amp;NR=1329604C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19940517&amp;DB=EPODOC&amp;CC=CA&amp;NR=1329604C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GEBERT, ULRICH</creatorcontrib><creatorcontrib>BARTLETT, ROBERT R</creatorcontrib><creatorcontrib>DICKNEITE, GERHARD</creatorcontrib><creatorcontrib>SCHORLEMMER, HANS U</creatorcontrib><creatorcontrib>SCHWAB, WILFRIED</creatorcontrib><creatorcontrib>SEDLACEK, HANS H</creatorcontrib><title>PHARMACEUTICALS, PHOSPHORUS-CONTAINING 2-ISOXAZOLINES AND ISOXAZOLES CONTAINED THEREIN, AND PROCESSES FOR THE PREPARATION OF THESE HETEROCYCLIC COMPOUNDS</title><description>Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds Pharmaceuticals containing or composed of at least one compound of the formula I and/or one of its physiologically tolerated salts where appropriate, where the compounds of the formula I can, where appropriate, be in the form of pure stereoisomers or mixtures thereof; formula I is: (I) in which R1 = organic radical or halogen, A = C,C single or C,C double bond, n = 0, 1 or 2, and X and Y = alkyl radical or = -OR2 or -NR2R3 with R2 and R3 = H or optionally substituted aliphatic radical. The pharmaceuticals are suitable for the prophylaxis and/or treatment of diseases of the immune system, especially of tumors, infections and/or autoimmune diseases of the human or animal body and for use as adjuvants for vaccines. Some of the compounds of the formula I are new; the compounds can be prepared by special processes.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjEEKwjAQRbtxIeoZzAEsaCuCy2E6NYGaCZkU1I2IxJWooJfxtqZS1y6Gz3__McPs7TT4LSC1wSA0MlNOs6TzreTINoCxxm5UkRvhHRy4MZZEga3UD6Tai1SpoMmTsbOv4TwjiSShZt9NiZADD8GwVVx3SEhpCpTMPTYG06ut49ZWMs4Gl9P1GSd9jrJpTQF1Hh_3Y3w-Tud4i68jwqIs1qv5Esv_xgcN-ELC</recordid><startdate>19940517</startdate><enddate>19940517</enddate><creator>GEBERT, ULRICH</creator><creator>BARTLETT, ROBERT R</creator><creator>DICKNEITE, GERHARD</creator><creator>SCHORLEMMER, HANS U</creator><creator>SCHWAB, WILFRIED</creator><creator>SEDLACEK, HANS H</creator><scope>EVB</scope></search><sort><creationdate>19940517</creationdate><title>PHARMACEUTICALS, PHOSPHORUS-CONTAINING 2-ISOXAZOLINES AND ISOXAZOLES CONTAINED THEREIN, AND PROCESSES FOR THE PREPARATION OF THESE HETEROCYCLIC COMPOUNDS</title><author>GEBERT, ULRICH ; BARTLETT, ROBERT R ; DICKNEITE, GERHARD ; SCHORLEMMER, HANS U ; SCHWAB, WILFRIED ; SEDLACEK, HANS H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA1329604C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1994</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GEBERT, ULRICH</creatorcontrib><creatorcontrib>BARTLETT, ROBERT R</creatorcontrib><creatorcontrib>DICKNEITE, GERHARD</creatorcontrib><creatorcontrib>SCHORLEMMER, HANS U</creatorcontrib><creatorcontrib>SCHWAB, WILFRIED</creatorcontrib><creatorcontrib>SEDLACEK, HANS H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GEBERT, ULRICH</au><au>BARTLETT, ROBERT R</au><au>DICKNEITE, GERHARD</au><au>SCHORLEMMER, HANS U</au><au>SCHWAB, WILFRIED</au><au>SEDLACEK, HANS H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICALS, PHOSPHORUS-CONTAINING 2-ISOXAZOLINES AND ISOXAZOLES CONTAINED THEREIN, AND PROCESSES FOR THE PREPARATION OF THESE HETEROCYCLIC COMPOUNDS</title><date>1994-05-17</date><risdate>1994</risdate><abstract>Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds Pharmaceuticals containing or composed of at least one compound of the formula I and/or one of its physiologically tolerated salts where appropriate, where the compounds of the formula I can, where appropriate, be in the form of pure stereoisomers or mixtures thereof; formula I is: (I) in which R1 = organic radical or halogen, A = C,C single or C,C double bond, n = 0, 1 or 2, and X and Y = alkyl radical or = -OR2 or -NR2R3 with R2 and R3 = H or optionally substituted aliphatic radical. The pharmaceuticals are suitable for the prophylaxis and/or treatment of diseases of the immune system, especially of tumors, infections and/or autoimmune diseases of the human or animal body and for use as adjuvants for vaccines. Some of the compounds of the formula I are new; the compounds can be prepared by special processes.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA1329604C
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICALS, PHOSPHORUS-CONTAINING 2-ISOXAZOLINES AND ISOXAZOLES CONTAINED THEREIN, AND PROCESSES FOR THE PREPARATION OF THESE HETEROCYCLIC COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A55%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GEBERT,%20ULRICH&rft.date=1994-05-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA1329604C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true